BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 946170)

  • 1. Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas.
    Zech L; Haglund U; Nilsson K; Klein G
    Int J Cancer; 1976 Jan; 17(1):47-56. PubMed ID: 946170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome abnormalities in Japanese Burkitt lymphoma cell lines.
    Hamasaki K
    Acta Med Okayama; 1982 Feb; 36(1):23-38. PubMed ID: 7064731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome #14 markers in two Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines of normal origin differ from the Burkitt lymphoma (BL)-associated 14q+ marker.
    Manolov G; Manolova Y; Klein G; Levan A; Kieler J
    Cancer Genet Cytogenet; 1981 Oct; 4(2):179-84. PubMed ID: 6277469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome 14 translocations in non-Burkitt lymphomas.
    Fukuhara S; Rowley JD
    Int J Cancer; 1978 Jul; 22(1):14-21. PubMed ID: 355152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of EBV association with non-random abnormalities of the chromosome region 1q21-25 in AIDS-related Burkitt's lymphoma-derived cell lines.
    Polito P; Cilia AM; Gloghini A; Cozzi M; Perin T; De Paoli P; Gaidano G; Carbone A
    Int J Cancer; 1995 May; 61(3):370-4. PubMed ID: 7729949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome 14 translocation in African and North American Burkitt's lymphoma;
    Kaiser-McCaw B; Epstein AL; Kaplan HS; Hecht F
    Int J Cancer; 1977 Apr; 19(4):482-6. PubMed ID: 844916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow karyotype analysis and fluorescence-activated sorting of Burkitt-lymphoma-associated translocation chromosomes.
    Wirschubsky Z; Perlmann C; Lindsten J; Klein G
    Int J Cancer; 1983 Aug; 32(2):147-53. PubMed ID: 6874139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stereotyped chromosome abnormalities in human leukemia and lymphoma].
    Berger R
    Presse Med; 1983 Dec; 12(46):2937-41. PubMed ID: 6228876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What's new in lymphoma cytogenetics?
    Kristoffersson U
    Pathol Res Pract; 1988 Feb; 183(1):100-6. PubMed ID: 3362747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ hybridization studies on variant t(2;8) translocations in Burkitt lymphoma lines.
    Hameister H; Adolph S
    Hum Genet; 1986 May; 73(1):73-6. PubMed ID: 3458667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of chromosomal findings for the differentiation between lymphoma and lymphoblastoid cell lines.
    Hellriegel KP; Diehl V; Krause PH; Meier S; Blankenstein M; Busche W
    Haematol Blood Transfus; 1977; 20():307-13. PubMed ID: 580253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogene expression in isogenic, EBV-positive and -negative Burkitt lymphoma cell lines.
    Glazer PM; Summers WC
    Intervirology; 1985; 23(2):82-9. PubMed ID: 2984143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Karyotype peculiarities of malignant lymphomas.
    Fleischman EW; Prigogina EL
    Hum Genet; 1977 Mar; 35(3):269-79. PubMed ID: 321328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative involvement of two cytogenetically distinguishable breakpoints on chromosome 8 in Burkitt's lymphoma associated translocations.
    Manolov G; Manolova Y; Klein G; Lenoir G; Levan A
    Cancer Genet Cytogenet; 1986 Feb; 20(1-2):95-9. PubMed ID: 3943061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome abnormalities in 16 Finnish patients with Burkitt's lymphoma or L3 acute lymphocytic leukemia.
    Knuutila S; Elonen E; Heinonen K; Borgström GH; Lakkala-Paranko T; Perkkiö M; Franssila K; Teerenhovi L; Ekblom M; von Willebrand E
    Cancer Genet Cytogenet; 1984 Oct; 13(2):139-51. PubMed ID: 6592036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 8-14 translocation in a Japanese Burkitt's lymphoma.
    Miyamoto K; Sato J; Miyoshi I; Nishihara R; Terao S; Hara M; Kimura I
    Acta Med Okayama; 1980 Mar; 34(2):139-42. PubMed ID: 6450516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 2p breakpoint of a 2;8 translocation in Burkitt lymphoma interrupts the V kappa locus.
    Emanuel BS; Selden JR; Chaganti RS; Jhanwar S; Nowell PC; Croce CM
    Proc Natl Acad Sci U S A; 1984 Apr; 81(8):2444-6. PubMed ID: 6585808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge.
    Boerma EG; Siebert R; Kluin PM; Baudis M
    Leukemia; 2009 Feb; 23(2):225-34. PubMed ID: 18923440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytogenetic markers and Burkitt-type malignant lymphomas].
    Lenoir GM; Philip T
    J Genet Hum; 1983 Mar; 31(1):53-5. PubMed ID: 6578298
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of Burkitt lymphoma-L3ALL with t(8;14) translocation, developed 10 years after Hodgkin's disease.
    Mandelli F; Martelli M; Cimino G; Alimena G; Anselmo AP; De Cuia MR; Gastaldi R; Arcese W; Papa G
    Scand J Haematol; 1985 Feb; 34(2):97-100. PubMed ID: 3856313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.